BioReference Acquires Edge BioServ to Incorporate into an Expanding GeneDx | GenomeWeb

This story was originally published Aug. 23.

BioReference Laboratories has acquired EdgeBio's sequencing services business Edge BioServ, which it will incorporate into its wholly-owned subsidiary GeneDx to enhance its sequencing capacity as the company's genetic testing business grows.

Sherri Bale, managing director of GeneDx, told Clinical Sequencing News that aside from additional sequencing capacity, the acquisition would also give GeneDx access to different sequencing platforms.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.